Filing Flows › Bristol Myers Squibb (BMY) › Recalls, complaints & regulation
Bristol Myers Squibb (BMY): recalls, EPA violations, clinical trials and Federal Register
Bristol Myers Squibb (BMY) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I); 3 EPA-regulated facilities in violation, $21K in penalties over five years; 6 Federal Register documents in a year; 209 active clinical trials.
Latest recalls
- 2025-10-29 · FDA drug · Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton,
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pennington, NJ | Violation Identified | $10K |
| BRISTOL MYERS SQUIBB INC | New Brunswick, NJ | Violation Identified | — |
| BRISTOL-MYERS SQUIBB CO | Princeton, NJ | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Bristol Myers Squibb's latest quarter
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
Has Bristol Myers Squibb had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Has Bristol Myers Squibb been fined by the EPA?
The 73 EPA-regulated facilities on file under its name drew $21K in penalties over five years; 3 are in violation now.
How many clinical trials does Bristol Myers Squibb have?
209 active studies on ClinicalTrials.gov, 68 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.